CEN/TC 140
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 67464 | LVS CEN/TS 17811:2022 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for urine and other body fluids - Isolated cell free DNA | Standarts spēkā |
| 22397 | LVS EN 13612:2003 /AC:2003 | Performance evaluation of in vitro diagnostic medical devices | Standarts spēkā |
| 5090 | LVS EN 1659:1996 | In vitro diagnostic systems - Culture media for microbiology - Terms and definitions | Standarts spēkā |
| 64279 | LVS EN ISO 22367:2020 | Medical laboratories - Application of risk management to medical laboratories (ISO 22367:2020) | Standarts spēkā |
| 60818 | EN ISO 15197:2015 | In vitro diagnostic test systems - Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (ISO 15197:2013) | Standarts spēkā |
| 27354 | LVS EN ISO 15194:2009 | In vitro diagnostic medical devices - Measurement of quantities in samples of biological origin - Requirements for certified reference materials and the content of supporting documentation (ISO 15194:2009) | Standarts spēkā |
| 68157 | EN ISO 15189:2022 | Medical laboratories - Requirements for quality and competence (ISO/DIS 15189:2021) | Standarts spēkā |
| 70932 | LVS EN ISO 18113-4:2024 | In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 4: In vitro diagnostic reagents for self-testing (ISO 18113-4:2022) | Standarts spēkā |
| 70930 | LVS EN ISO 18113-2:2024 | In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 2: In vitro diagnostic reagents for professional use (ISO 18113-2:2022) | Standarts spēkā |
| 61690 | LVS EN ISO 20166-2:2019 | Molecular in vitro diagnostic examinations - Specifications for pre-examinations processes for formalin-fixed and paraffin-embedded (FFPE) tissue - Part 2: Isolated proteins (ISO 20166-2:2018) | Standarts spēkā |
Displaying 201-210 of 275 results.